Angiotensin 1-9 vs Apelin-17 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Angiotensin 1-9 (Ang 1-9) is a 9-amino acid peptide formed when ACE2 cleaves the C-terminal leucine from angiotensin I (Ang I, 10 AA). Discovered as part of the counter-regulatory renin-angiotensin system (RAS), Ang 1-9 opposes the hypertensive and tissue-damaging actions of angi...
Calculate Angiotensin 1-9 dose →Apelin-17 is a 17-amino acid C-terminal fragment of the prepro-apelin precursor that binds and activates the APJ receptor (now APLNR) with the highest potency of all naturally occurring apelin isoforms. While apelin-13 is the best-characterized isoform, apelin-17 shows greater re...
Calculate Apelin-17 dose →| Parameter | Angiotensin 1-9 | Apelin-17 |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Preclinical Research | Preclinical / Phase I |
| Half-Life | ~20-30 minutes | ~3-5 minutes IV (longer than apelin-13) |
| Typical Dose | 40-400 ng/kg/min IV infusion (animal) | 30-100 nmol/kg/min (IV infusion, clinical) |
| Frequency | Acute infusion protocols | Acute infusion protocols |
| Route | IV/SC (research) | IV infusion (clinical studies); SC under investigation |
| FDA Status | Research compound | Investigational (Phase I/II) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.